Compare MRNA & NXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | NXT |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 13.2B |
| IPO Year | 2018 | 2023 |
| Metric | MRNA | NXT |
|---|---|---|
| Price | $51.78 | $105.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 20 |
| Target Price | $32.75 | ★ $94.42 |
| AVG Volume (30 Days) | ★ 11.8M | 1.6M |
| Earning Date | 02-13-2026 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.85 |
| Revenue | $2,232,000,000.00 | ★ $3,373,226,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | $3.18 | $11.52 |
| P/E Ratio | ★ N/A | $26.04 |
| Revenue Growth | N/A | ★ 20.37 |
| 52 Week Low | $22.28 | $36.06 |
| 52 Week High | $50.00 | $112.74 |
| Indicator | MRNA | NXT |
|---|---|---|
| Relative Strength Index (RSI) | 82.55 | 65.32 |
| Support Level | $39.21 | $92.46 |
| Resistance Level | $41.98 | $100.94 |
| Average True Range (ATR) | 2.93 | 5.18 |
| MACD | 1.57 | 1.18 |
| Stochastic Oscillator | 87.75 | 95.32 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.